SMi’s ‘Asthma & COPD’ returns to London in March 2017 to reflect on the ongoing issues and latest developments to these two diseases.
DESCRIPTION: The SMi Group is proud to announce the return of the 13th annual Asthma & COPD conference taking place in London on the 29-30 March 2017. Aimed at senior scientists and respiratory and inhalation specialists, Asthma & COPD 2017 will reflect on the ongoing issues and latest developments of these two diseases. With a carefully selected panel of industry experts, the 2017 event will address the latest challenges and changes in the fields of asthma and COPD. The agenda will explore ongoing issues, cutting edge developments and novel approaches to treatment surrounding key areas such as biomarkers and targeted treatment, device development and drug delivery. Furthermore the event will deepen understanding of the problems relating to these respiratory diseases, and discuss the hot topic of electronic health monitoring. Hear from MHRA, Mylan, AstraZeneca, Teva UK, GlaxoSmithKline, Boehringer Ingelheim, Glenmark Pharmaceuticals, Janssen, AstraZeneca, Novartis and many more… Early birds available.
For details please visit: www.asthma-copd.co.uk/bentham
Related Journal: Current Respiratory Medicine Reviews
Related eBook: Frontiers in Clinical Drug Research-Anti Infectives